American Heart Association Scientific Sessions 2020

Blacks, Hispanics Had Higher Rates of Hospitalization, Mortality from COVID-19

According to new data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, Black and Hispanic patients accounted for more than half of hospitalizations...
High Dose Flu Shot More Effective in RA Patients 

High-Dose Influenza Vaccine Similar to Standard-Dose for All-Cause Death, Cardiopulmonary Events

High-dose inactivated influenza vaccine did not reduce all-cause death or hospitalization for cardiopulmonary causes compared with a standard-dose vaccine in patients with high-risk cardiovascular...
Rivaroxaban Plus Aspirin Lowers Vs. Aspirin Alone in Those With Prior PCI

Rivaroxaban Plus Aspirin Reduced Cardiac, Limb Events in PAD After LER

Rivaroxaban plus aspirin reduced ischemic risk of the limb, brain, and heart in peripheral artery disease (PAD) after lower extremity revascularization (LER), according to...
Doctor examing clip board

Rivaroxaban Monotherapy Safe for AF After Coronary Stenting

The benefit of rivaroxaban monotherapy for patients with atrial fibrillation (AF) after coronary stenting was dependent on the duration of time from stenting, according...
Doctors with Clipboard

40% of Middle-Aged Swedes Had Silent CAD

Four out of 10 people in a middle-age population in Sweden had coronary artery disease (CAD), with one in 20 having severe CAD, according...
Evolocumab Associated with Reduced Risk for Complex Revascularization

Rates of Thromboembolic Complications High in COVID-19+ ICU Patients

Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), major adverse cardiovascular events, and...
A mid adult male doctor sits at a table across from an unrecognizable patient. He holds up a prescription bottle as he explains the benefits and risks of a new medication.

Rivaroxaban Plus Aspirin Protects Against Venous, Arterial Thrombotic Events After LER

Peripheral artery disease (PAD) was associated with continuous and linearly increasing risk for venous thromboembolism (VTE) after lower extremity revascularization (LER). Low-dose rivaroxaban plus...

Recent Cardiology Headlines

LIFE: Sacubitril-Valsartan Safe in Advanced HF, No Effect on NT-proBNP

LIFE: Sacubitril-Valsartan Safe in Patients with Advanced HF, But Without Significant Effect on NT-proBNP

Editor's Note: This dispatch from ACC.21 was written by Mark Belkin, MD, a cardiology fellow at the University of Chicago. Dr. Belkin is also...
Alcohol Consumption Increases Risk for AFib and AFib Events

HOLIDAY Monitors Study: Alcohol Consumption Increases Risk for AFib and AFib Events

New research suggests that alcohol consumption is associated with a rapid increase in the risk for atrial fibrillation (AFib) and AFib events, new research...
Another Win for HF Patients: REHAB-HF Shows Benefit and Value for Focused Rehab Programs

Another Win for HF Patients: REHAB-HF Shows Benefit and Value for Focused Rehab Programs

Editor’s Note: This dispatch from ACC.21 was written by Devesh Rai, MD, a chief resident at Rochester General Hospital. Dr. Rai is also a...
FLOWER-MI: FFR-guided PCI for STEMI Yields No Additional Benefit

FLOWER-MI: FFR-guided PCI for STEMI Yields No Additional Benefit

The use of fractional flow reserve (FFR)-guidance for coronary stenting after an ST-segment elevation myocardial infarction (STEMI) did not add benefit, according to new...